Related Experiment Video
Updated: May 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
TRAF4 is a critical molecule for Akt activation in lung cancer
Wei Li1, Cong Peng, Mee-Hyun Lee
1Authors' Affiliations: The Hormel Institute, University of Minnesota, Austin, Minnesota; Cancer Research Institute, Xiangya School of Medicine; Xiangya Hospital, Central South University, Changsha, Hunan; The First Affiliated Hospital; and Physiology and Pathophysiology, Basic Medical School, Zhengzhou University, Zhengzhou, Henan, China.
Abstract:
TRAF4 is an adapter protein overexpressed in certain cancers, but its contributions to tumorigenesis are unclear. In lung cancer cells and primary lung tumors, we found that TRAF4 is overexpressed. RNA interference-mediated attenuation of TRAF4 expression blunted the malignant phenotype in this setting, exerting inhibitory effects on cell proliferation, anchorage-independent growth, and tumor development in a xenograft mouse model. Unexpectedly, we discovered that TRAF4, but not Skp2, was required for activation of the pivotal cell survival kinase Akt through ubiquitination. Furthermore, TRAF4 attenuation impaired glucose metabolism by inhibiting expression of Glut1 and HK2 mediated by the Akt pathway. Overall, our work suggests that TRAF4 offers a candidate molecular target for lung cancer prevention and therapy.
Insights
Tumorigenesis involves the adapter protein TRAF4 (TNF receptor associated factor 4), which is overexpressed in lung cancer. TRAF4 activates Akt kinase, promoting cancer cell survival and growth, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor necrosis factor receptor associated factor 4 (TRAF4) is an adapter protein implicated in various cancers.
- Its specific role in lung tumorigenesis and its molecular mechanisms remain largely unelucidated.
Purpose of the Study:
- To investigate the role of TRAF4 in lung cancer development and progression.
- To elucidate the molecular pathways through which TRAF4 influences cancer cell phenotypes.
Main Methods:
- Utilized RNA interference to attenuate TRAF4 expression in lung cancer cells.
- Assessed effects on cell proliferation, anchorage-independent growth, and tumor development in a xenograft mouse model.
- Investigated TRAF4's role in Akt kinase activation and glucose metabolism regulators (Glut1, HK2).
Main Results:
- TRAF4 is overexpressed in lung cancer cells and primary tumors.
- TRAF4 depletion significantly inhibited cancer cell proliferation, anchorage-independent growth, and tumor formation in vivo.
- TRAF4, independent of Skp2, was essential for Akt kinase activation via ubiquitination.
- TRAF4 attenuation impaired glucose metabolism by downregulating Akt-mediated Glut1 and HK2 expression.
Conclusions:
- TRAF4 plays a critical role in promoting lung cancer cell proliferation, survival, and tumor development.
- TRAF4's mechanism involves the activation of the Akt signaling pathway, impacting glucose metabolism.
- TRAF4 represents a potential molecular target for novel lung cancer therapies.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: